These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. [Treatment of pneumococcal meningitis]. Pinilla Llorente B; García Castaño J; González Parra S; Muiño Míguez A An Med Interna; 1994 May; 11(5):256. PubMed ID: 8061145 [No Abstract] [Full Text] [Related]
26. Empirical Treatment in Acute Bacterial Meningitis: a Plea for High Doses of Cefotaxime or Ceftriaxone. Le Turnier P; Tattevin P; Varon E; Duval X Antimicrob Agents Chemother; 2023 Apr; 67(4):e0001223. PubMed ID: 36880753 [No Abstract] [Full Text] [Related]
27. Cefotaxime failure in pneumococcal meningitis caused by a susceptible isolate. Flórez C; Silva G; Martín E Pediatr Infect Dis J; 1996 Aug; 15(8):723-4. PubMed ID: 8858688 [No Abstract] [Full Text] [Related]
29. Influence of dexamethasone on efficacy of ceftriaxone and vancomycin therapy in experimental pneumococcal meningitis. Cabellos C; Martinez-Lacasa J; Martos A; Tubau F; Fernández A; Viladrich PF; Gudiol F Antimicrob Agents Chemother; 1995 Sep; 39(9):2158-60. PubMed ID: 8540738 [TBL] [Abstract][Full Text] [Related]
30. Early vancomycin therapy and adverse outcomes in children with pneumococcal meningitis. Buckingham SC; McCullers JA; Luján-Zilbermann J; Knapp KM; Orman KL; English BK Pediatrics; 2006 May; 117(5):1688-94. PubMed ID: 16651325 [TBL] [Abstract][Full Text] [Related]
31. New concepts in the management of infants and children with meningitis. McCracken GH Pediatr Infect Dis; 1983; 2(3 Suppl):S51-5. PubMed ID: 6306611 [No Abstract] [Full Text] [Related]
32. Increasing incidence of penicillin- and cefotaxime-resistant Verghese VP; Veeraraghavan B; Jayaraman R; Varghese R; Neeravi A; Jayaraman Y; Thomas K; Mehendale SM Indian J Med Microbiol; 2017; 35(2):228-236. PubMed ID: 28681811 [TBL] [Abstract][Full Text] [Related]
33. New cephalosporins cefotaxime, cefpimizole, BMY 28142, and HR 810 in experimental pneumococcal meningitis in rabbits. Täuber MG; Hackbarth CJ; Scott KG; Rusnak MG; Sande MA Antimicrob Agents Chemother; 1985 Mar; 27(3):340-2. PubMed ID: 3838872 [TBL] [Abstract][Full Text] [Related]
34. Ribosomal DNA assay of culture-negative Streptococcus pneumoniae meningitis. Janner DL; Probert WS; McClure CD Pediatr Neurol; 2007 Jul; 37(1):55-8. PubMed ID: 17628224 [TBL] [Abstract][Full Text] [Related]
35. The emergence of resistant pneumococcal meningitis--implications for empiric therapy. McMaster P; McIntyre P; Gilmour R; Gilbert L; Kakakios A; Mellis C Arch Dis Child; 2002 Sep; 87(3):207-10. PubMed ID: 12193427 [TBL] [Abstract][Full Text] [Related]
36. Cefotaxime use in pediatric infections. Dajani AS Diagn Microbiol Infect Dis; 1995; 22(1-2):105-10. PubMed ID: 7587022 [TBL] [Abstract][Full Text] [Related]
37. [Vancomycin in meningitis caused by penicillin G resistant Streptococcus pneumoniae]. Longuet P; Vallée E; Michel M; Perronne C; Janvier M; Leport C; Vildé JL Presse Med; 1993 Nov; 22(36):1818-9. PubMed ID: 8309909 [TBL] [Abstract][Full Text] [Related]
38. Management of meningitis caused by penicillin-resistant Streptococcus pneumoniae. París MM; Ramilo O; McCracken GH Antimicrob Agents Chemother; 1995 Oct; 39(10):2171-5. PubMed ID: 8619561 [No Abstract] [Full Text] [Related]
39. Penicillin-resistant pneumococcal meningitis in Israel. Steinberg T; Rachmel A; Samra Z; Ashkenazi S Isr J Med Sci; 1997 Nov; 33(11):757-9. PubMed ID: 9434816 [TBL] [Abstract][Full Text] [Related]